FIM Capital Appoint New Non-Executive Chairman

FIM Capital appoint new non-executive chairman

He has more than 40 years’ experience in the finance industry

FIM Capital announces non-exec Chairman

Industry veteran Richard Brindley joins Board of FIM Capital as CEO cites taking business to 'next level'. The post FIM Capital announces non-exec Chairman appeared first on Investment International.

Smith+Nephew appoint David King as a non-executive director

Save Smith+Nephew has announced that David King will join the board as an independent non-executive director with effect from 1 July 2025. He will serve as a member of the compliance & culture and the remuneration committees. King is currently CEO, executive director and chair of Fortis Life Sciences. He also serves, or has recently served, as a chair or non-executive director on the boards of several US healthcare companies, including ZimVie (2…

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc (LON:SN, NYSE: SNN), the global medical technology company, has announced that David King will join the Board as an independent Non-Executive Director with effect from 1 July 2025. David will serve as a member of the Compliance & Culture and the Remuneration Committees. David is currently CEO, executive director and chair of Fortis Life Sciences. He also serves, or has recently served, as a Chair or non-executive director on t…